Adam H Schechter
CIK 1376841 · President & CEO · last filed 2026-05-18
Adam H Schechter is a President & CEO who has filed 110 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for DVA, was dated May 18, 2026. Across all open-market trades the lifetime net is −$78.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $53.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$53.60M
4
110
-$78.65M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DVA | Director | 5,692 | $208.66 | $1.19M | $0 | 15 | 2026-05-18 |
| LH | President & CEO | 107,234 | $266.16 | $28.54M | -$13.19M | 45 | 2026-05-13 |
| MRK | EVP & Pres-Global Human Health | 200,540 | $119.05 | $23.87M | -$65.46M | 49 | 2018-11-02 |
| Merck & Co., Inc. (MRKpB) Delisted | EVP & Pres-Global Human Health | 9,803 | — | — | $0 | 1 | 2010-05-11 |
Recent Filings
110 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-18 | DVA | Grant (A) | +250 | $0 | EDGAR |
| 2026-05-13 | LH | Sell (S) | −5,903 | -$1.50M | EDGAR |
| 2026-03-30 | LH | Mixed | +32,364 | -$7.01M | EDGAR |
| 2026-03-17 | DVA | Grant (A) | +332 | $0 | EDGAR |
| 2026-03-05 | LH | Sell (S) | −8,705 | -$2.44M | EDGAR |
| 2026-02-13 | LH | Mixed | −3,138 | -$1.94M | EDGAR |
| 2026-02-12 | LH | Grant (A) | — | $0 | EDGAR |
| 2026-02-10 | LH | Mixed | +5,042 | -$735.0K | EDGAR |
| 2025-11-17 | DVA | Grant (A) | +411 | $0 | EDGAR |
| 2025-11-13 | LH | Sell (S) | −5,745 | -$1.51M | EDGAR |